Analysis
| Revenue estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 7 | 7 | 13 | 13 |
| Avg. estimate | 784.13B | 840.72B | 3.26T | 3.42T |
| Low estimate | 754.90B | 831.50B | 3.19T | 3.34T |
| High estimate | 803.85B | 854.50B | 3.36T | 3.53T |
| Last year sales | 765.73B | 812.77B | 41.98B | 3.26T |
| Sales growth | 0.02 | 0.03 | 76.74 | 0.05 |
| EPS trend |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 0.16 | 0.19 | 0.69 | 0.75 |
| 7 days ago | 0.18 | 0.20 | 0.72 | 0.78 |
| 30 days ago | 0.18 | 0.20 | 0.71 | 0.77 |
| 60 days ago | 0.18 | 0.20 | 0.71 | 0.78 |
| 90 days ago | 0 | 0 | 0.68 | 0 |
| EPS revisions |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 1 | 1 | 1 | 1 |
| Up last 30 days | 1 | 1 | 1 | 1 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 0 | 0 | 0 | 0 |